- Home
- MLAB vs SFST Comparison
MLAB vs SFST Comparison
Compare MLAB & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MLAB | SFST |
|---|---|---|
| Founded | 1982 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Major Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.8M | 429.7M |
| IPO Year | 1995 | 2012 |
Fundamental Metrics
Financial Performance| Metric | MLAB | SFST |
|---|---|---|
| Price | $82.61 | $52.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $94.00 | $64.00 |
| AVG Volume (30 Days) | ★ 116.1K | 73.6K |
| Earning Date | 02-03-2026 | 04-21-2026 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | ★ 99.24 | 94.76 |
| EPS | 1.95 | ★ 3.72 |
| Revenue | N/A | ★ $6,282,000.00 |
| Revenue This Year | $6.07 | $10.47 |
| Revenue Next Year | $5.41 | $12.19 |
| P/E Ratio | $41.18 | ★ $13.73 |
| Revenue Growth | N/A | ★ 12.99 |
| 52 Week Low | $59.63 | $29.80 |
| 52 Week High | $130.12 | $62.00 |
Technical Indicators
Market Signals| Indicator | MLAB | SFST |
|---|---|---|
| Relative Strength Index (RSI) | 45.24 | 34.71 |
| Support Level | $69.73 | $50.27 |
| Resistance Level | $89.69 | $52.60 |
| Average True Range (ATR) | 4.40 | 1.83 |
| MACD | -0.87 | -0.41 |
| Stochastic Oscillator | 46.07 | 13.01 |
Price Performance
Historical ComparisonAbout MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. Through its banking subsidiary, it is engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer, and mortgage loans, ATM processing, and other banking products and services to the general public. The group operates through various retail offices located in the Greenville, Columbia, and Charleston markets of South Carolina, three retail offices in the Raleigh, Greensboro, and Charlotte markets of North Carolina, and one retail office in Atlanta, Georgia.